Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma V. Toscano Introduction 11 April 2014 Pages: 546 - 550
Polycystic ovary syndrome — loss of the apoptotic mechanism in the ovarian follicles? Roy HomburgA. Amsterdam Views on Pathogenetic Mechanisms 11 April 2014 Pages: 552 - 557
Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset Lourdes IbáñezF. de ZegherN. Potau Views on Pathogenetic Mechanisms 11 April 2014 Pages: 558 - 566
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies Randall B. Barnes Views on Pathogenetic Mechanisms 11 April 2014 Pages: 567 - 579
Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome Enrico CarminaR. A. Lobo Views on Pathogenetic Mechanisms 11 April 2014 Pages: 580 - 588
Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style? Jan Holte Views on Pathogenetic Mechanisms 11 April 2014 Pages: 589 - 601
Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome Janet E. HallA. E. TaylorW. F. Crowley Jr. Views on Pathogenetic Mechanisms 11 April 2014 Pages: 602 - 611
How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism Dan Apter Opinions on Therapeutic Aspects 11 April 2014 Pages: 613 - 617
Estrogen — Progestagen therapy in the management of the polycystic ovary syndrome John C. Marshall Opinions on Therapeutic Aspects 11 April 2014 Pages: 618 - 622
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome? Evanthia Diamanti-Kandarakis Opinions on Therapeutic Aspects 11 April 2014 Pages: 623 - 629
The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists Sarah L. Berga Opinions on Therapeutic Aspects 11 April 2014 Pages: 630 - 631
Attenuation of hyperinsulinemia in polycystic ovary syndrome: What are the options? David A. Ehrmann Opinions on Therapeutic Aspects 11 April 2014 Pages: 632 - 635
How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome? C. Cortet-RudelliDidier Dewailly Opinions on Therapeutic Aspects 11 April 2014 Pages: 636 - 640
New routes in the polycystic ovary syndrome labyrinth: A way out? Paolo MoghettiR. Castello Conclusion 11 April 2014 Pages: 648 - 655
